tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CLLS Stock Latest News

Cellectis SA Schedules Shareholder Meeting and Proposes Capital Changes
Company AnnouncementsCellectis SA Schedules Shareholder Meeting and Proposes Capital Changes
52m ago
6K
CLLS
Monthly information on share capital and company voting rights
PremiumPress Releases
Monthly information on share capital and company voting rights
8d ago
CLLS
Monthly information on share capital and company voting rights
PremiumPress Releases
Monthly information on share capital and company voting rights
18d ago
CLLS
Cellectis Bolstered by $140M AstraZeneca Investment
PremiumCompany Announcements
Cellectis Bolstered by $140M AstraZeneca Investment
18d ago
6K
CLLS
Cellectis announces completion of $140M investment from AstraZeneca
PremiumThe Fly
Cellectis announces completion of $140M investment from AstraZeneca
19d ago
AZN
CLLS
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
PremiumPress ReleasesCellectis Announces Completion of the Additional Equity Investment by AstraZeneca
19d ago
CLLS
Cellectis Announces Leadership Shift in Finance
PremiumCompany Announcements
Cellectis Announces Leadership Shift in Finance
21d ago
6K
CLLS
Cellectis appoints Arthur Stril as interim CFO
PremiumThe Fly
Cellectis appoints Arthur Stril as interim CFO
22d ago
CLLS
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
PremiumPress Releases
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
22d ago
CLLS
Cellectis reports Q1 EPS (59c), consensus (22c)
PremiumThe Fly
Cellectis reports Q1 EPS (59c), consensus (22c)
25d ago
CLLS
Cellectis Unveils Groundbreaking Gene-Editing Advances
PremiumCompany Announcements
Cellectis Unveils Groundbreaking Gene-Editing Advances
1M ago
6K
CLLS
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
PremiumPress Releases
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
1M ago
CLLS
Cellectis Unveils Gene Therapy Breakthrough
PremiumCompany AnnouncementsCellectis Unveils Gene Therapy Breakthrough
1M ago
6K
CLLS
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs
PremiumPress Releases
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs
1M ago
CLLS
Cellectis publishes new research paper in Molecular Therapy
PremiumThe Fly
Cellectis publishes new research paper in Molecular Therapy
1M ago
CLLS
Cellectis Unveils Breakthrough Gene-Editing Innovations
PremiumCompany Announcements
Cellectis Unveils Breakthrough Gene-Editing Innovations
2M ago
6K
CLLS
Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting
PremiumPress Releases
Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting
2M ago
CLLS
Monthly information on share capital and company voting rights
PremiumPress Releases
Monthly information on share capital and company voting rights
2M ago
CLLS
Is CLLS a Buy, Before Earnings?
PremiumPre-Earnings
Is CLLS a Buy, Before Earnings?
3M ago
CLLS
Monthly information on share capital and company voting rights
PremiumPress ReleasesMonthly information on share capital and company voting rights
3M ago
CLLS
Monthly information on share capital and company voting rights
PremiumPress Releases
Monthly information on share capital and company voting rights
4M ago
CLLS
Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)
PremiumPress Releases
Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)
4M ago
CLLS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >